Simple and rapid plaque assay for recombinant baculoviruses expressing influenza hemagglutinin. 2021

Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.

Recombinant baculoviruses (rBVs) have been extensively used to generate virus-like particles, and baculoviruses expressing antigenic proteins have become efficient tools for inducing protective immunity. However, current methods for generating baculoviruses are costly and inefficient. Thus, the development of a simple, rapid, and accurate method of baculovirus titration is critically important. We established a method of plaque assay using an immunostaining method by which plaques can be easily visualized in Sf9 cells under a light microscope. Sf9 cells were infected with recombinant baculoviruses expressing influenza hemagglutinin surface proteins from H1N1 (A/California/04/09) or rH5N1 (A/Vietnam/1203/04). The infected cells were incubated with anti-HA antibody and the plaques were visualized using the chromogen 3'3-diaminobenzidine (DAB). Plaques were observed from days 1 to 6 post-infection, and differences in Sf9 cell seeding densities resulted in variations in the final plaque quantification. Sf9 cells seeded at a concentration of 5.5 × 104 cells/well or 7.5 × 104 cells/well showed the higher plaque titers at days 3, 4, and 5 post-infection than those found at days 1, 2, and 6 post-infection. With 5.5 × 104 cells/well or 7.5 × 104 cells/well of cell concentrations, recombinant baculovirus for rBV-HA (H1N1) showed 6 × 107 pfu/ml of titer and rBVs for rBV-HA (rH5N1) showed 5.4 × 107 pfu/ml of titer. Three days of baculovirus incubation with a certain concentration of Sf9 cells seeded are required for a rapid, simple, and accurate plaque assay, which could significantly contribute to all baculovirus-related studies.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D006388 Hemagglutinins Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. Isohemagglutinins,Exohemagglutinins,Hemagglutinin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D016367 Baculoviridae Family of INSECT VIRUSES which contain polyhedron-shaped or ovocylindrical occlusion bodies. The genera include ALPHABACULOVIRUS; GAMMABACULOVIRUS; and DELTABACULOVIRUS (commonly known as NUCLEOPOLYHEDROVIRUSES) and BETABACULOVIRUS (commonly known as GRANULOVIRUSES). Baculovirus vectors are used for expression of foreign genes in insects and as BIOPESTICIDES for controlling insect populations. Baculovirus,Baculoviruses
D053118 Influenza A Virus, H1N1 Subtype A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918 and 2009 H1N1 pandemic. H1N1 Influenza Virus,H1N1 Virus,H1N1 subtype,H1N1v Viruses,Influenza A (H1N1)pdm09,Influenza A (H1N1)pdm09 Virus,Influenza A H1N1, Variant Virus,Swine-Origin Influenza A H1N1 Virus,H1N1 Influenza Viruses,H1N1 Viruses,H1N1 subtypes,H1N1v Virus,Influenza Virus, H1N1,Swine Origin Influenza A H1N1 Virus,Virus, H1N1,Virus, H1N1 Influenza,Virus, H1N1v,subtype, H1N1

Related Publications

Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
April 2016, Scientific reports,
Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
March 2019, Virology,
Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
August 1991, BioTechniques,
Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
January 1979, Intervirology,
Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
June 2023, Journal of virological methods,
Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
July 2017, Journal of immunological methods,
Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
August 2021, Proceedings of the National Academy of Sciences of the United States of America,
Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
June 2017, Analytical chemistry,
Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
January 1982, Archives of virology,
Swarnendu Basak, and Hae-Ji Kang, and Ki-Back Chu, and Judy Oh, and Fu-Shi Quan
November 2008, Influenza and other respiratory viruses,
Copied contents to your clipboard!